top of page
PRRT (1200 × 300 px).png

PRRT Resources


Peptide Receptor Radionuclide Therapy (PRRT) Active Clinical Trials 


Jan 2024 - LACNETS Educational Event.png
LACNETS Educational Event
January 11, 2024

Join us on Thursday, January 11th at 9:30 AM Pacific to learn the latest on PRRT with NET expert Dr. Jonathan Strosberg. Dr. Strosberg was the principal investigator of the NETTER-1 study which led to the FDA approval of Lutathera and has authored numerous articles on PRRT. He will discuss the latest in PRRT, including special considerations and current clinical trials. 

Watch "The Latest in PRRT" with Dr. Carina Mari Aparici. This presentation is part of the 2023 LACNETS Neuroendocrine Tumor Patient Education Conference held on June 17, 2023.

Nuclear Medicine Physician and Theranostics Director at Fred Hutchinson Cancer Center, Dr. Amir Iravani, shares the latest on Peptide Receptor Radionuclide Therapy (PRRT). Better understand the difference between beta and alpha PRRT, current trials and updates on PRRT for Lung NET, adolescents and dosimetry.

NET expert and radiologist Dr. Thomas Hope of UCSF addresses the latest in NET imaging and PRRT.

Nuclear Medicine Physician Dr. Erik Mittra provides an update on PRRT. Plus, hear from a NET patient who has received multiple rounds of PRRT treatments.

Nuclear medicine specialist Dr. Delpassand provides an update on the exciting advances in NET Management including Cu64 DOTATATE & Alpha PRRT.



PRRT Patient/Caregiver Stories

PRRT Patient/Caregiver Stories

Watch Now


Podcast 9 (Podcast) (1).png

Administrative Nurse Lindy Gardner of UCLA Health answers 10 common questions about the before, during and after of PRRT.

Podcast 9 (Podcast) (2).png

Nuclear Medicine Physician Dr. Martin Auerbach of UCLA Health answers 10 common questions about the decision-making process of PRRT.

Podcast 10 (Podcast) (1).png

Patient advocate Josh Mailman answers ten common questions about the past, present, and future of PRRT.